Cargando…
Data-driven design of targeted gene panels for estimating immunotherapy biomarkers
Tumour mutation burden and other exome-wide biomarkers are used to determine which patients will benefit from immunotherapy. However, the cost of whole exome sequencing limits the widespread use of such biomarkers. Here, we introduce a data-driven framework for the design of targeted gene panels for...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866421/ https://www.ncbi.nlm.nih.gov/pubmed/35197525 http://dx.doi.org/10.1038/s42003-022-03098-1 |